The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Virophta     1-[(2R,4S,5R)-4-hydroxy-5...

Synonyms: Viroptic, Fluridine, TFDU, Trifluridina, Trifluridine, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Viroptic


Psychiatry related information on Viroptic


High impact information on Viroptic


Chemical compound and disease context of Viroptic


Biological context of Viroptic


Anatomical context of Viroptic


Associations of Viroptic with other chemical compounds


Gene context of Viroptic


Analytical, diagnostic and therapeutic context of Viroptic


  1. Trifluridine for herpes zoster. Harris, D.J. N. Engl. J. Med. (1994) [Pubmed]
  2. Topical trifluridine for mucocutaneous acyclovir-resistant herpes simplex II in AIDS patient. Murphy, M., Morley, A., Eglin, R.P., Monteiro, E. Lancet (1992) [Pubmed]
  3. Combination therapy of dendritic keratitis with trifluorothymidine and interferon. Sundmacher, R., Cantell, K., Neumann-Haefelin, D. Lancet (1978) [Pubmed]
  4. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Kaufmann, S.H., Desnoyers, S., Ottaviano, Y., Davidson, N.E., Poirier, G.G. Cancer Res. (1993) [Pubmed]
  5. Multicenter trial of acyclovir and trifluorothymidine in herpetic keratitis. La Lau, C., Oosterhuis, J.A., Versteeg, J., van Rij, G., Renardel de Lavalette, J.G., Craandijk, A., Lamers, W.R., Mierlobensteyn, T. Am. J. Med. (1982) [Pubmed]
  6. Virus chemotherapy: antiviral drugs and interferon. Kaufman, H.E., Varnell, E.D., Centifanto-Fitzgerald, Y.M., Sanitato, J.G. Antiviral Res. (1984) [Pubmed]
  7. Use of 5-trifluoromethyldeoxycytidine and tetrahydrouridine to circumvent catabolism and exploit high levels of cytidine deaminase in tumors to achieve DNA- and target-directed therapies. Mekras, J.A., Boothman, D.A., Greer, S.B. Cancer Res. (1985) [Pubmed]
  8. Expression of herpes virus thymidine kinase in Neurospora crassa. Sachs, M.S., Selker, E.U., Lin, B., Roberts, C.J., Luo, Z., Vaught-Alexander, D., Margolin, B.S. Nucleic Acids Res. (1997) [Pubmed]
  9. Effectiveness of acycloguanosine and trifluorothymidine as inhibitors of cytomegalovirus infection in vitro. Lang, D.J., Cheung, K.S. Am. J. Med. (1982) [Pubmed]
  10. The incorporation of trifluorothymidine into calf thymus DNA in a cell-free system does not lead to chain termination. Sarrif, A.M., Tone, H., Danenberg, P.V., Heidelberger, C. Mol. Pharmacol. (1980) [Pubmed]
  11. Mechanism-based inhibition of thymidylate synthase by 5-(trifluoromethyl)-2'-deoxyuridine 5'-monophosphate. Eckstein, J.W., Foster, P.G., Finer-Moore, J., Wataya, Y., Santi, D.V. Biochemistry (1994) [Pubmed]
  12. Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus. Coster, D.J., McKinnon, J.R., McGill, J.I., Jones, B.R., Fraunfelder, F.T. J. Infect. Dis. (1976) [Pubmed]
  13. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model. Romanowski, E.G., Bartels, S.P., Gordon, Y.J. Invest. Ophthalmol. Vis. Sci. (1999) [Pubmed]
  14. TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine. McGregor, D.B., Brown, A.G., Cattanach, P., Shepherd, W., Riach, C., Daston, D.S., Caspary, W.J. Carcinogenesis (1989) [Pubmed]
  15. Effect of azone and propylene glycol on penetration of trifluorothymidine through skin and efficacy of different topical formulations against cutaneous herpes simplex virus infections in guinea pigs. Spruance, S.L., McKeough, M., Sugibayashi, K., Robertson, F., Gaede, P., Clark, D.S. Antimicrob. Agents Chemother. (1984) [Pubmed]
  16. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections. Birch, C.J., Tyssen, D.P., Tachedjian, G., Doherty, R., Hayes, K., Mijch, A., Lucas, C.R. J. Infect. Dis. (1992) [Pubmed]
  17. In vitro toxicological evaluation of ISIS 1082, a phosphorothioate oligonucleotide inhibitor of herpes simplex virus. Crooke, R.M., Hoke, G.D., Shoemaker, J.E. Antimicrob. Agents Chemother. (1992) [Pubmed]
  18. Spontaneous mutation rates in mammalian cells: effect of differential growth rates and phenotypic lag. Rudd, C.J., Daston, D.S., Caspary, W.J. Genetics (1990) [Pubmed]
  19. Irinotecan-induced cytotoxicity to colon cancer cells in vitro is stimulated by pre-incubation with trifluorothymidine. Temmink, O.H., Hoebe, E.K., Fukushima, M., Peters, G.J. Eur. J. Cancer (2007) [Pubmed]
  20. Update on antiviral agents. Kaufman, H.E. Ophthalmology (1985) [Pubmed]
  21. The hollow fibre assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells. Temmink, O.H., Prins, H.J., van Gelderop, E., Peters, G.J. Br. J. Cancer (2007) [Pubmed]
  22. Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuin. Fiume, L., Mattioli, A., Balboni, P.G., Tognon, M., Barbanti-Brodano, G., de Vries, J., Wieland, T. FEBS Lett. (1979) [Pubmed]
  23. Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cells. Temmink, O.H., Hoebe, E.K., van der Born, K., Ackland, S.P., Fukushima, M., Peters, G.J. Br. J. Cancer (2007) [Pubmed]
  24. Corneal wound healing and antiviral medication. Foster, C.S., Pavan-Langston, D. Arch. Ophthalmol. (1977) [Pubmed]
  25. Potential treatment of herpes simplex virus encephalitis by brain-specific delivery of trifluorothymidine using a dihydropyridine in equilibrium pyridinium salt type redox delivery system. Rand, K.H., Bodor, N., el Koussi, A.A., Raad, I., Miyake, A., Houck, H., Gildersleeve, N. J. Med. Virol. (1986) [Pubmed]
  26. Intraocular antiviral penetration. Poirier, R.H., Kingham, J.D., de Miranda, P., Annel, M. Arch. Ophthalmol. (1982) [Pubmed]
  27. Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity. de Bruin, M., van Capel, T., Van der Born, K., Kruyt, F.A., Fukushima, M., Hoekman, K., Pinedo, H.M., Peters, G.J. Br. J. Cancer (2003) [Pubmed]
  28. Unstable, non-mutational expression of resistance to the thymidine analogue, trifluorothymidine in CHO cells. Adair, G.M., Carver, J.H. Mutat. Res. (1979) [Pubmed]
  29. Trifluridine, cidofovir, and penciclovir in the treatment of experimental herpetic keratitis. Kaufman, H.E., Varnell, E.D., Thompson, H.W. Arch. Ophthalmol. (1998) [Pubmed]
  30. 5-Azacytidine inhibits the induction of transient TK-deficient cells by 5-bromodeoxyuridine. A novel hypothesis for the facilitation of hypermethylation by 5-bromodeoxyuridine. Call, K.M., Thilly, W.G. Mutat. Res. (1991) [Pubmed]
  31. Human interferon alpha A or alpha D and trifluridine treatment for herpetic keratitis in rabbits. Trousdale, M.D., Nesburn, A.B. Invest. Ophthalmol. Vis. Sci. (1984) [Pubmed]
  32. Tk+/- mouse model for detecting in vivo mutation in an endogenous, autosomal gene. Dobrovolsky, V.N., Casciano, D.A., Heflich, R.H. Mutat. Res. (1999) [Pubmed]
  33. Intracellular thymidylate synthase inhibition by trifluorothymidine in FM3A cells. Temmink, O.H., Comijn, E.M., Fukushima, M., Peters, G.J. Nucleosides Nucleotides Nucleic Acids (2004) [Pubmed]
  34. Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir. Larder, B.A., Darby, G. Antimicrob. Agents Chemother. (1986) [Pubmed]
  35. Trifluridine decreases ocular HSV-1 recovery, but not herpetic lesions after timolol iontophoresis. Rootman, D.S., Hill, J.M., Haruta, Y., Reidy, J.J., Kaufman, H.E. Invest. Ophthalmol. Vis. Sci. (1989) [Pubmed]
  36. Use of an enzyme-linked immunosorbent assay performed directly on fixed infected cell monolayers for evaluating drugs against varicella-zoster virus. Berkowitz, F.E., Levin, M.J. Antimicrob. Agents Chemother. (1985) [Pubmed]
  37. Antiviral update. Kaufman, H.E. Ophthalmology (1979) [Pubmed]
  38. Role of débridement and trifluridine (trifluorothymidine) in herpes simplex dendritic keratitis. Parlato, C.J., Cohen, E.J., Sakauye, C.M., Dreizen, N.G., Galentine, P.G., Laibson, P.R. Arch. Ophthalmol. (1985) [Pubmed]
  39. Determination of trifluorothymidine in the eye using high-performance liquid chromatography. Riegel, M.R., Ellis, P.P. J. Chromatogr. (1991) [Pubmed]
WikiGenes - Universities